ShopSpell

Immunotherapy of Cancer [Hardcover]

$170.99     $219.99   22% Off     (Free Shipping)
100 available
  • Category: Books (Medical)
  • ISBN-10:  1588295648
  • ISBN-10:  1588295648
  • ISBN-13:  9781588295644
  • ISBN-13:  9781588295644
  • Publisher:  Humana
  • Publisher:  Humana
  • Pages:  528
  • Pages:  528
  • Binding:  Hardcover
  • Binding:  Hardcover
  • Pub Date:  01-Mar-2005
  • Pub Date:  01-Mar-2005
  • SKU:  1588295648-11-SPRI
  • SKU:  1588295648-11-SPRI
  • Item ID: 100802520
  • List Price: $219.99
  • Seller: ShopSpell
  • Ships in: 5 business days
  • Transit time: Up to 5 business days
  • Delivery by: Nov 30 to Dec 02
  • Notes: Brand New Book. Order Now.

Expert bench and clinical scientists join forces to concurrently review both the state-of-the-art in tumor immunology and its clinical translation into promising practical treatments. The authors explain in each chapter the scientific basis behind such therapeutic agents as monoclonal antibodies, cytokines, vaccines, and T-cells, and illustrate their clinical manipulation to combat cancer. Additional chapters address statistical analysis-both of clinical trials and assay evaluations-methods for the discovery of antigens, adoptive T cell therapy, and adaptive and innate immunity. The challenges in clinical trial design, the need for biomarkers of response-such as novel imaging techniques and immunologic monitoring-and the new advances and directions in cancer immunotherapy are also fully examined.Expert bench and clinical scientists join forces to concurrently review both the state-of-the-art in tumor immunology and its clinical translation into promising practical treatments. The authors explain in each chapter the scientific basis behind such therapeutic agents as monoclonal antibodies, cytokines, vaccines, and T-cells, and illustrate their clinical manipulation to combat cancer. Additional chapters address statistical analysis-both of clinical trials and assay evaluations-methods for the discovery of antigens, adoptive T cell therapy, and adaptive and innate immunity. The challenges in clinical trial design, the need for biomarkers of response-such as novel imaging techniques and immunologic monitoring-and the new advances and directions in cancer immunotherapy are also fully examined.Discovery of Target Molecules for Cancer Immunotherapy by Genetic and Bioinformatic Approaches?zlem T?reci, Thorsten Klamp, Michael Koslowski, Sebastian Kreiter, and Ugur SahinCurrent Strategies for the Identification of Immunogenic Epitopes of Tumor AntigensLudmila M?ller, Stephanie McArdle, Evelyna Derhovanessian, Thomas Flad, Ashley Knights, Robert Rees, and Graham PawelecCurrenlƒs

Add Review